Onconetix Stock Analysis

Onconetix Stock Analysis Notes

About 58.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.15. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Onconetix recorded a loss per share of 87.25. The entity had not issued any dividends in recent years. The firm had 1:40 split on the 24th of September 2024. Oncology Med, Inc. offer full service cancer center solutions. To find out more about Onconetix contact the company at 513 620 4101 or learn more at https://onconetix.gcs-web.com.

Onconetix Investment Alerts

Onconetix Upcoming and Recent Events

Onconetix Largest EPS Surprises

View All Earnings Estimates

Onconetix Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 4.69 M.

Onconetix Profitablity

Management Efficiency

Onconetix has return on total asset (ROA) of (0.2185) % which means that it has lost $0.2185 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (17.5848) %, meaning that it created substantial loss on money invested by shareholders. Onconetix's management efficiency ratios could be used to measure how well Onconetix manages its routine affairs as well as how well it operates its assets and liabilities. As of the 31st of January 2025, Return On Tangible Assets is likely to grow to -6.36. In addition to that, Return On Capital Employed is likely to drop to -0.62. At this time, Onconetix's Total Assets are very stable compared to the past year. As of the 31st of January 2025, Non Current Assets Total is likely to grow to about 98.6 M, while Other Assets are likely to drop 0.80.

Technical Drivers

As of the 31st of January, Onconetix holds the Variance of 151.97, risk adjusted performance of (0.14), and Coefficient Of Variation of (555.06). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Onconetix, as well as the relationship between them.

Onconetix Price Movement Analysis

Onconetix Insider Trading Activities

Onconetix Predictive Daily Indicators

Onconetix Forecast Models

Onconetix's time-series forecasting models are one of many Onconetix's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Onconetix's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Onconetix prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Onconetix shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Onconetix. By using and applying Onconetix Stock analysis, traders can create a robust methodology for identifying Onconetix entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Onconetix analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Onconetix analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Onconetix stock analysis indicators help investors evaluate how Onconetix stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Onconetix shares will generate the highest return on investment. By understating and applying Onconetix stock analysis, traders can identify Onconetix position entry and exit signals to maximize returns.

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Onconetix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in Onconetix Stock, please use our How to Invest in Onconetix guide.You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Onconetix. If investors know Onconetix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Onconetix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Onconetix is measured differently than its book value, which is the value of Onconetix that is recorded on the company's balance sheet. Investors also form their own opinion of Onconetix's value that differs from its market value or its book value, called intrinsic value, which is Onconetix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Onconetix's market value can be influenced by many factors that don't directly affect Onconetix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Onconetix's value and its price as these two are different measures arrived at by different means. Investors typically determine if Onconetix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Onconetix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.